Cirata PLC Reports Record Data Integration Bookings and Strong Growth in FY25 Preliminary Results

Record data integration bookings show Cirata's strong momentum, but cash flow challenges and customer concentration remain key watchpoints for investors.

31 March 2026by Joshua Thompson5 min read17 views

This article covers information on Cirata PLC.

LON:CRTA

Cirata’s FY25: record Data Integration bookings, leaner cost base, and a cleaner story

Cirata has posted a punchy set of preliminary FY25 numbers. The company doubled total bookings, delivered its strongest Data Integration (DI) bookings since 2017, and signed the biggest direct and OEM deals in its history. It also sold the DevOps unit, trimmed costs hard, and wrapped up the FCA investigation with no further action.

The flip side: cash fell during the year, finance costs spiked, and the auditors flag a material uncertainty around going concern if sales underwhelm. Management is targeting cash flow positive in Q1 FY26 and break-even for FY26 overall, but enterprise software remains lumpy by nature.

Headline metrics investors should know

Metric (FY25)	FY25	FY24
Total bookings	$13.9m	$7.1m
Data Integration bookings	$13.2m	$4.7m
Q4 DI bookings	$9.8m	$2.3m
Revenue – continuing operations	$11.9m	$4.6m
Total revenue	$13.6m	$7.7m
Adjusted EBITDA loss	$3.8m	$14.4m
Operating loss – continuing	$4.6m	$15.8m
Total cash overheads	$16.1m	$20.6m
Cash at 31 Dec	$4.0m	$9.7m
Cash + short-term receivables	$7.4m	Not disclosed
Deferred income (current + non-current)	$0.19m	$2.33m

Jargon buster: bookings are the total value of contracts signed; OEM refers to sales via a partner that embeds or resells the product; adjusted EBITDA is operating profit before non-cash charges and certain items; ACV (Annual Contract Value) is the annualised value of recurring contracts; LDM is Cirata’s Live Data Migrator.

What drove the beat: an enterprise push and bigger commitments

DI bookings surged 181% to $13.2m, with a blockbuster Q4 of $9.8m. Management had flagged a back-end weighted year, and that is exactly what landed. The company signed a $6.7m three-year OEM deal via IBM and a $3.1m three-year direct deal with a leading US insurer – both record sizes and both multi-year. These lend credibility to LDM and show larger enterprises are committing for longer.

Equally important, Cirata leaned into “expansion wins” – selling more into existing large accounts as data volumes and use cases grow. That tends to deliver better unit economics and stickier relationships, even if timing remains lumpy.

Symphony launch broadens the story beyond migration

September saw the launch of Cirata Symphony, a data orchestration platform that moves the company beyond pure migration into coordinating and monitoring complex data estates. This widens the addressable market and should complement DI sales among Global 2000 customers. Early interest is described as encouraging and has helped lead generation into FY26. Hard revenue figures for Symphony are not disclosed yet.

Share𝕏 in

Investing
Polar Capital Technology Trust Reports 102% NAV Growth in Stellar Fiscal Year
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Investing

Tagged

Last updated

5 July 2026

Star Rating

No ratings yet

Cost discipline is now a real lever

Cirata is a much slimmer operation. The annualised cash overhead run-rate exiting Q4 FY25 is $12-13m, down from a peak above $41.5m and from approximately $16-17m a year earlier. Adjusted EBITDA loss shrank to $3.8m, and the operating loss from continuing operations narrowed to $4.6m.

The DevOps disposal brought in $3.4m and removed distraction. The group is now fully focused on DI and orchestration – areas aligned with the AI and modern analytics build-out inside large enterprises.

Revenue quality, concentration and cash dynamics

Geography: North America drove $9.6m of continuing revenue, the UK $1.9m, and the rest of the world $0.4m.
Customer concentration: the top customer accounted for 47% of revenue, with the top three at 83%. That is high and worth monitoring as the new logo strategy ramps.
Contract assets: accrued income rose sharply, with total contract assets at $5.6m (from $0.4m). Deferred income fell to $0.19m (from $2.33m). This mix suggests timing differences between revenue recognition and cash collection. Collections and ACV disclosures will matter in FY26.

Cash, finance costs and going concern

Year-end cash was $4.0m, plus $3.4m of short-term trade receivables, giving $7.4m combined. Cash burn reduced versus FY24 thanks to lower costs and stronger bookings, but cash still declined through the year.

Finance costs jumped to $6.9m (from $0.1m), turning net finance income into a net finance cost of $6.8m. The RNS does not break down the drivers of this spike. Total loss for the year improved to $7.1m (from $13.5m), helped by a $4.0m gain on the DevOps sale within discontinued operations.

On going concern, the board highlights a material uncertainty. In its Base case, with an annualised overhead of about $12-13m, the group expects to meet obligations. In a Severe but Plausible Downside (lower sales, no mitigating cost cuts), cash would reduce to minimal levels by 31 October 2026. There is no bank debt; lease liabilities total $0.47m.

FY26 outlook: targets and milestones to watch

Operating expense run-rate: approximately $12-13m.
Cash flow: targeting positive in Q1 FY26 and planning for cash flow break-even for FY26 overall, subject to bookings timing and working capital.
KPIs: ACV will be introduced as a key growth measure given its closer tie to cash collection.
Go-to-market: leadership changes led by the CRO, Dominic Arcari, are expected to improve visibility by mid-year. Management still expects a non-linear pattern typical of enterprise software.
Next catalyst: a Q1 trading update is expected in mid-April.

The IBM relationship and OEM route

The $6.7m, three-year OEM contract via IBM is the largest in company history and is an encouraging signal for partner-led scale. If the IBM channel continues to deliver, it could reduce sales-cycle risk and customer concentration over time. That said, OEM timelines can be just as lumpy as direct, so consistency will be the test.

Regulatory clean-up completed

The FCA investigation concluded with no further action. That removes an overhang and should make conversations with enterprises and partners more straightforward.

Josh’s view: a tighter ship with real momentum, but still lumpy and concentrated

There is a lot to like here. DI bookings at $13.2m, record Q4 momentum, and two landmark multi-year contracts show the strategy is resonating with large enterprises. The cost base reset is meaningful – a $12-13m run-rate gives Cirata operating leverage if bookings repeat with more consistency. The launch of Symphony expands the opportunity set.

On the risk side, revenue is concentrated in a handful of customers, finance costs spiked (cause not disclosed), and the auditors point to a material uncertainty on going concern under a downside case. With contract assets rising and deferred income falling, cash conversion and ACV disclosures will be key tells in FY26.

What to watch next: confirmation of cash flow positivity in Q1; the pace of new logo wins versus expansion deals; traction of Symphony in Global 2000 accounts; growth through IBM and other partners; and any reduction in customer concentration. Deliver a couple more quarters like Q4, and the narrative shifts decisively from turnaround to scale-up. Miss the timing windows, and the cash cushion will feel thin again.